• Globe Newswire

Io Therapeutics, Inc. announces publication of studies on the company’s RXR agonist compound IRX4204 for breast cancer prevention

Globenewswire -

• Globe Newswire

First half of 2025: Solid growth, investments and pipeline progress pave the way for two key launches in H2

Globenewswire -

• Globe Newswire

Olon Group Strengthens Its Leadership in Bioproduction with Two Strategic Appointments in France

Globenewswire -

• Globe Newswire

Boehringer Ingelheim announces succession Chairmen Shareholders’ Committee and Board of Managing Directors

Globenewswire -

• Globe Newswire

Boehringer Ingelheim announces plans to advance potential new treatment for Geographic Atrophy, following positive Phase I results

• Globe Newswire

Olon Continues its Growth Path and Announces a New Acquisition

• Globe Newswire

Olon Group Announces the Acquisition of GTP Bioways Group